Shay Capital’s GSK GSK Stock Holding History

Shay Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,000	Closed	-$569K	–	487
2023 Q1	$569K	Sell	16,000 -101,799	-86%	-$3.56M	0.11%	155
2022 Q4	$4.14M	Buy	+117,799	New	+$3.92M	1.28%	13
2022 Q3	–	Sell	-120	Closed	-$7K	–	407
2022 Q2	$7K	Buy	+120	New	+$6.63K	﹤0.01%	409

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Shay Capital's GSK Position: Q2 2023 in Review

Shay Capital sold out of GSK (GSK) in Q2 2023, closing a stake of 16,000 shares — an estimated $569K sold.

Shay Capital first reported a position in GSK in Q2 2022 and held it in 3 quarters. The position peaked at $4.14M in Q4 2022. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

Shay Capital reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
Shay Capital sold 16,000 GSK shares in Q2 2023, an estimated $569K.
Shay Capital first reported a position in GSK in Q2 2022 and held it in 3 quarters.
Shay Capital's GSK position peaked at $4.14M in Q4 2022.
827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Shay Capital's 13F filing for Q2 2023, filed 14 Aug 2023.